Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News St. Vincent & Grenadines.
Press releases published on August 14, 2025
Basilea gibt Einlizenzierung eines neuartigen oralen Antibiotikums bekannt, das bereit für die klinische Phase-3-Entwicklung ist
GlobeNewswire
·
August 14, 2025
Ad hoc-Mitteilung gemäss Art. 53 KR Allschwil, 14. August 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren Infektionen durch …
Basilea announces in-licensing of a novel clinical phase 3-ready oral antibiotic
GlobeNewswire
·
August 14, 2025
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, August 14, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal …
Communiqué de presse : Le rilzabrutinib de Sanofi obtient la désignation de médicament orphelin dans l’UE pour la maladie liée aux IgG4
GlobeNewswire
·
August 14, 2025
Le rilzabrutinib de Sanofi obtient la désignation de médicament orphelin dans l’UE pour la maladie liée aux IgG4 Données de l’étude positive de phase 2 évaluant le rilzabrutinib pour le traitement de la maladie liée aux IgG4 présentée à l’EULAR de 2025 …
Zealand Pharma Announces Financial Results for the First Half of 2025
GlobeNewswire
·
August 14, 2025
Company announcement – No. 18 / 2025 Zealand Pharma Announces Financial Results for the First Half of 2025 Petrelintide collaboration with Roche off to a strong start, while key leadership appointments and solid financial position enable exciting next …
Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease
GlobeNewswire
·
August 14, 2025
Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease Data from the positive Phase 2 study evaluating rilzabrutinib for the treatment of IgG4-related disease presented at EULAR 2025 Additional orphan designation underscores …
Intuitive Machines Announces Upsize and Pricing of Private Offering of $300 Million of Convertible Senior Notes Due 2030
GlobeNewswire
·
August 14, 2025
HOUSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR) (“Intuitive Machines” or the “Company”), a leading space exploration, infrastructure, and services company, announced today the pricing of $300.0 million aggregate principal …
SELECTQUOTE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against SelectQuote, Inc. - SLQT
GlobeNewswire
·
August 14, 2025
NEW ORLEANS, Aug. 13, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 10, 2025 to file lead plaintiff applications in a securities class action lawsuit against SelectQuote, Inc. …
FLYWIRE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Flywire Corporation - FLYW
GlobeNewswire
·
August 14, 2025
NEW ORLEANS, Aug. 13, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 23, 2025 to file lead plaintiff applications in a securities class action lawsuit against Flywire …
NEOGEN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Neogen Corporation - NEOG
GlobeNewswire
·
August 14, 2025
NEW ORLEANS, Aug. 13, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 16, 2025 to file lead plaintiff applications in a securities class action lawsuit against Neogen …
SABLE OFFSHORE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Sable Offshore Corp. - SOC
GlobeNewswire
·
August 14, 2025
NEW ORLEANS, Aug. 13, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 26, 2025 to file lead plaintiff applications in a securities class action lawsuit against Sable Offshore …
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
GlobeNewswire
·
August 14, 2025
NEW ORLEANS, Aug. 13, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims …
Acceleware Ltd. Announces Closing of Shares for Debt Transactions
GlobeNewswire
·
August 14, 2025
CALGARY, Alberta, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of cutting-edge radio frequency (“RF”) power-to-heat technologies targeting process heat for critical minerals, amine …